Transcatheter Coil Embolization in Coronary Artery Fistulae by Setianto, Budi Y & Arshant, Pudya L
CASE  REPORT
55Acta Medica Indonesiana - The Indonesian Journal of Internal Medicine
Transcatheter Coil Embolization in Coronary Artery Fistulae
Budi Y. Setianto1,2, Pudya L. Arshant2
1 Department of Cardiology and Vascular Medicine, Gadjah Mada University - dr. Sardjito Hospital. Jl. Kesehatan 
Sekip no. 1, Yogyakarta, Indonesia.
2 Department of Internal Medicine, Gadjah Mada University - dr. Sardjito Hospital, Yogyakarta, Indonesia.
Correspondence mail: budyuls@yahoo.com.
ABSTRAK
Fistula arteri koroner atau coronary artery fistulae (CAF) merupakan kelainan yang jarang terjadi, sebagian 
besar bersifat kongenital dengan insidens sebesar 0,1% - 0,2% dan insidens CAF yang didapat sebesar 0,2%, 
sebagaimana ditunjukkan oleh angiografi koroner. CAF dengan pintas aliran tinggi (high flow shunting) atau 
yang bersifat simtomatik harus ditangani dengan pembedahan atau teknik tertentu tanpa pembedahan seperti 
embolisasi dengan kumparan lintas kateter atau transcatheter coil embolization (TCCE).
Artikel ini menyajikan suatu kasus, yakni seorang wanita berusia 63 tahun dengan keluhan utama nyeri 
dada sejak satu bulan yang lalu. Pasien telah menjalani angiografi koroner yang menunjukkan adanya 95% 
penyempitan sisi proksimal arteri desenden anterior bawah atau LAD (left anterior descendens) dan CAF dari 
LAD ke atrium kanan. Untuk penyempitan LAD sebelah proksimal telah ditangani dengan PCI (percutaneous 
coronary intervention) dan implantasi stent bersalut obat (drug eluting stents), tetapi pasien tetap mengeluhkan 
nyeri dada yang dialaminya. Para dokter memutuskan untuk melakukan TCEE untuk menangani CAF. Setelah 
dilakukan TCEE, pasien tidak lagi mengeluhkan nyeri dada dan evaluasi dengan EKG menunjukkan hasil yang 
normal.
Kata kunci: fistula arteri koroner, simtomatik, transcatheter coil embolization.
ABSTRACT
Coronary artery fistulae (CAF) is a rare anomaly, mostly with the incidence of congenital CAF 0.1% - 0.2% 
and the incidence of acquired CAF 0.2% at coronary angiography. Symptomatic or high flow shunting CAF 
must be treated with surgery or non surgery approach such as transcatheter coil embolization (TCCE).
A women 63 years old with chief complain of chest pain since one month ago. The patient had undergone 
coronary angiography with conclusions as follows 95% narrowing of proximal LAD (left anterior descendens) 
artery and CAF from LAD into the right atrium. Whereas narrowing of proximal LAD was performed PCI 
(percutaneous coronary intervention) with the implantation of drug eluting stents, but patients still complained 
chest pain. CAF decided to do the TCCE. Post TCCE chest pain and ECG evaluation were within normal limits.
Key words: coronary artery fistulae, symptomatic, transcatheter coil embolization.
INTRODUCTION
Most coronary artery fistulae (CAF) are 
asymptomatic, but some are symptomatic 
because of manifestation of coronary steal such 
as angina pectoris, myocardial infarction, heart 
failure, endocarditis, and aneurysm formation. 
Triad diagnostic of CAF is a location of abnormal 
murmur ‘to and fro’ corresponding persistent 
ductus arteriosus (PDA), a left to right shunt in 
atrium or ventricle and turtoisity of coronary.1-3 
The gold standard diagnostic of CAF is coronary 
angiography.4,5
Indications therapy of CAF are asymptomatic 
patients with high - flow shunts and the presence 
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of symptoms. The goal of therapy to prevent 
symptom or complication.2,5-7 Clinical signs 
related to increased morbidity and mortality. 
Fistulae-related complications especially in 
elderly and mortality increases with age.8 
Therapy strategies of CAF are divided into 
conservative therapy, surgical and transcatheter 
coil embolization (TCCE). The success of 
surgery is quite high but the risk of cardiac 
arrest.1,9 TCCE technique is choice of treatment 
because of the cost-effectiveness, and less risk 
compared than surgery.7,9
CASE ILUSTRATION
A 63-year-old female patient that was treated 
with chief complaint of chest pain came and went 
since one month ago. The patient, non-obese 
diabetes mellitus (DM2NO), hypertension and 
coronary artery disease, one vessel disease (CAD-
1VD) post stenting dated January 15, 2010 with 
the conclusion in the following, proximal LAD 
95% stenosis, found the coronary artery fistulae 
from LAD into the right atrium. Other vessels are 
within normal limits. On physical examination 
there is no murmur or others abnormality. ECG 
finding shows ventricle extra systole (VES). The 
working diagnosis is observation of chest pain 
may caused by CAF, CAD-1VD post stenting, 
VES, hypertension and DM2NO. The patient is 
administered by clopidogrel 75 mg twice a day, 
bisoprolol 5 mg once a day, valsartan 160 mg once 
a day, and Insulin gargline 26 units subcutaneous 
a day. The patient underwent trancatheter coil 
embolization (TCCE) on February 17, 2010 in 
the catheterization laboratory of Dr. Sardjito 
Hospital, Yogyakarta. The result had been installed 
two coil units with no residual fistulae, no chest 
pain anymore and no significant complications. 
Another problem has not been controlled was 
hypertension, so that given additional therapy 
with amlodipine 5 mg once a day and patients 
discharged after controlled blood pressure.
DISCUSSION
Coronary artery fistulae (CAF) is a 
relationship between one or more coronary 
arteries with a heart space or large vessel through 
myocardial basis, was first reported by Krauss 
in 1865.1-3 In embryology, CAF divided into 
congenital and acquired. Congenital coronary 
artery fistulae caused by failure of obliteration 
of the sinusoids intramyocardial is due to 
defects in embryonic development of coronary 
arterial branches between the ages of 6-8 
weeks of life.1,10 Postulate pathophysiology of 
congenital CAF originating from the two forms 
of embryologic growth disorders. Based on 
fetal growth retardation, Steinberg, Dotter and 
Baldwin divided CAF into type 1 due to coronary 
capillary element differentiation defect and type 
2 are anomalous origin of coronary arteries with 
concomitant inter-coronary relationship due to 
defect formation of a primitive septum bulb.11 
Approximately 0.25 to 0.4% CAF associated 
with other congenital heart diseases such as 
atrial septal defect (ASD), tetralogy of Fallot 
(TOF), persistent ductus arteriosus (PDA), 
ventricular septal defect (VSD) and pulmonary 
atresia.8 Acquired coronary artery fistulae can 
result from blunt or penetrating trauma, post-
cardiac surgery (valve replacement, transplant-
coronary artery bypass, coronary angioplasty, 
re-post myocardial biopsy in heart transplant) 
and the omission of CABG through the coronary 
veins or complications of myocardial infarction 
(rare).1-3 Normal anatomy of the main coronary 
artery has two branches of right coronary artery 
(RCA) and left main coronary artery (LMCA), 
which branched into left circumflex (LCX) and 
left anterior descendens (LAD).13 Normally, the 
two major coronary arteries from aortic sinus 
occur consecutively, but one or more branches 
of the fistulae connects directly with a heart 
chamber or pulmonary trunk, coronary sinus, 
superior vena cava or pulmonary veins showed 
a shortcut left-to-right. Great shunts happen if 
CAF ended up in the atrium space.14 Coronary 
artery fistulae can arise from several parts of the 
three major coronary arteries. CAF generally 
grow from the RCA or LAD, LCX is rarely 
involved. Most of the CAF originated from the 
RCA or the branches (55%), 30% of the LAD 
and 5% bilateral.2,5,15 Ninety percent of the CAF 
ended on the right side of the heart, usually on 
the single surface. Location drainage is the most 
Figure 1. CAF from the LAD into the right atrium pre and 
post TCCE
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low-pressure structure, including the right of 
heart chamber, pulmonary artery, superior vena 
cava and coronary sinus. Most end up in the right 
ventricle (45%), then the right atrium (25%), 
pulmonary trunk (15%), coronary sinus (7%), left 
atrium (5%) and left ventricle (3%).2,7,8,16
Coronary artery fistulae in these patients was 
likely congenital because there was no history of 
or risk factor for acquired CAF. LAD coronary 
fistulae originated from and ended up in right 
atrium. LAD artery as a place of origin of CAF 
found on 30% of cases, and CAF in the right 
atrial endings in 25% of cases. Forty percent up 
to 55% patients with CAF are asymptomatic. 
Patients can be asymptomatic in several years, 
then experienced symptoms of cardiovascular 
disorders such as growth and development 
in childhood, fatigue, dyspnea, orthopnea, 
palpitations, angina pectoris, myocardial 
ischemia or infarction, stroke, congestive heart 
failure, chest pain atypical, subacute bacterial 
endocarditis or arrhythmias (such as premature 
ventricular contractions, atrial tachycardia, 
ventricular tachycardia, bundle branch block 
and 1st degree atrioventricular block) or sudden 
death.4,5,7,17 Clinical presentation of the CAF 
is influenced by age, severity of left-to-right 
shunt, the size and structure of relationships. 
In theory, CAF ‘steal’ of coronary blood flow 
(coronary steal) from the origin of coronary 
artery fistulae, resulting in a decrease in coronary 
blood flow resulting in ischemia of the distal 
CAF or myocardial infarction which gives the 
manifestation of chest pain.5,10 These alerts can 
be worsened by other cardiac conditions such 
as coronary artery disease, valve disease and 
myocardial hypertrophy.1 Physical examination 
revealed no sign if there was no ischemia or 
myocardial infarction. The first clinical signs 
may include sudden death in young athletes 
and military personnel.18,19 Most asymptomatic 
patients referred for unexplained angina, 
congestive heart failure or continuous murmur 
that sounded most loudly in the precordial. 
Murmur tends to crescendo -decrescendo systolic 
and diastolic, but even harder on the diastolic. 
Conversely, most continuous murmur reaches 
peak intensity in the second heart sound. Location 
of continuous murmur will be heard at the 
entrance to the heart fistulae. If the CAF entrance 
on the right atrium, the loudest murmur heard 
at the bottom along the sternal border. If CAF 
entered the pulmonary artery or right ventricle, 
the loudest murmur heard at the left sternal 
spatium intercostal 2-3 and if it went into the left 
ventricle most obvious murmur near the apex. If 
CAF is connected with the left ventricle, probably 
just sounded early-diastolic murmur.1,2,5,21 Haller-
and Little describe the triad of diagnostic CAF. 
An abnormal location of murmur "to and from" 
in line with the persistent ductus arteriosus, a the 
left to right shunt on atrial or ventricular levels 
and coronary artery winding (turtousity).5 Chest 
radiography is generally within normal limits 
or cardiomegaly with increased vascularities, 
especially if there is a great left-to-right shunt.1,2,15 
Electrocardiography (ECG) is generally normal 
or ischemic changes that show the effects of 
ventricular volume overload or left ventricular 
hypertrophy left, right or both.1,2 Trans thoracal 
echocardiography (TTE) - two dimensions 
demonstrated the large coronary artery dilatation. 
Turbulence pattern of continuous systolic 
and diastolic flow describe the location of the 
beginning of the shunt, dilated nutrient arteries 
or twisting with abnormal flow patterns. Shunt 
size are classified based on the ratio of pulmonary 
to systemic flow ratio (Qp/Qs). High-flow 
shunts if the ratio Qp/Qs >1.5. The ratio of Qp/
Qs in the CAF typically <1.5 and rarely >2.1,17 
Transesophageal echocardiography (TEE) with 
descriptions include dilatation of the heart 
chamber, color flow doppler jet narrowest >4 mm 
or descending aortic back flow.24 Resolution of 
TEE is higher because the transducer is placed in 
the esophagus, just behind and very close to the 
left atrium and thoracic aorta.4,22 Treadmill test 
results can be positive ischemic response.16 ECG 
changes on the treadmill test can occur if there 
are other cardiovascular conditions.1 Coronary 
angiography is the gold standard diagnosis 
of CAF because it can accurately describe 
the origin, size, number and flow fistulae and 
presence of aneurysm. Coronary angiography 
in congenital heart disease is the classification 
of the recommendations of ACC/AHA class I, 
level of evidence C.21 Angiography aimed to 
find influence of coronary lesions on coronary 
hemodynamic and knowing abnormality.2,21 
Coronary magnetic resonance angiography 
(CMRA), more and more used to know the 
anatomy of the coronary anomaly due to non-
invasive, able to identify the main causes of CAF 
and thus their minimizing radiation exposure is 
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an ideal procedure.19 This patient complained 
recurrent chest pain though the patients were 
diabetic patients and post stenting one month 
before. Chest pain was suspected because of 
ischemia or infarction due to coronary steal 
phenomenon. Chest pain in patients with DM is 
very meaningful, because it possible existence 
of neuropathy. Physical examination found no 
noisy heart. Results of laboratory and others 
have hyperglycemia within normal limits. Results 
of chest X-ray within normal limits and ECG 
demonstrated VES. Therapy indication of CAF is 
that there are clinical signs (symptomatic), mainly 
heart failure and asymptomatic myocardial 
ischemia as well as CAF with high-flow shunt. 
The goal of therapy is to prevent the signs or 
complications, especially in childhood. Closure 
of fistulae absolutely be done immediately to 
prevent complications.2,5-7 There are three options 
CAF governance namely conservative, surgical 
and transcatheter coil embolization (TCCE). 
Conservative therapy is performed for small 
and asymptomatic CAF. Antiplatelet therapy is 
recommended especially at the distal CAF and 
abnormal coronary arteries are dilated. Suggested 
prophylactic sub-acute bacterial endocarditis due 
to a complication of coronary fistulae.7 Definitive 
therapy of CAF is usually needed cardiac surgery. 
CAF surgical therapy was first performed Bjork 
and Crafoord in 1947.20 Small or asymptomatic 
CAF surgery remains controversial because of 
losses due to surgery.13 Indications of surgery 
include shunt ratio >30%, signs of ischemia, 
pulmonary hypertension, congestive heart failure, 
aneurysm formation, large CAF with high-flow 
shunt, relationships and multiple endings, the 
need for coronary bypass-simultaneous and social 
reasons.3,4,7,23 Complete occlusion of fistulae 
after surgery achieving >95%. Morbidity and 
mortality of surgery 0-6%, myocardial infarction 
<5% and risk-recurrent fistulae.1-3,7,8,14 TCCE 
technique was first performed in 1982. This 
therapy is effective, safe and complete occlusion 
was achieved >95%. TCCE successful therapy 
is similar to surgical therapy in patients without 
cardiac surgery-related morbidity due to avoid 
medial sternotomy and cardiopulmonary bypass. 
TCCE purpose is occlusion of the arteries and 
fistulae as distal as and as close as possible to the 
end point to prevent the possibility of occlusion 
of the branches of myocardial normal. Blockage 
of arteries that were treated at the first level of 
branches and reduction of shunts left-to-right 
so-closure of post myocardial perfusion became 
normal. That is too distal embolization, and if 
there is no significant stenosis in blood vessels, 
embolization may occur migration tools out 
fistulae and into the pulmonary circulation.2,5,6,9,24 
TCCE therapy is recommended during secure 
access to the nutrient artery, single fistulae, there 
are no multiple large branches, no vessels are 
extremely winding, narrow single-stream location 
and the little branches of blood vessels. Despite 
extensive fistulae with rapid blood flow, TCCE still 
can be done because at least supplementing, the 
existence of an optimal location for the main coil 
and attached to flow into the aneurysm location is 
relatively narrow and restrictive.7,9
The choice of techniques influenced the 
age, size of catheters that can be used, size of 
blood vessels that will be occluded and bend 
the catheter to reach the point of occlusion 
fistulae, and nutrient artery morphology as well 
as price considerations. Morphology fistulae 
include a bend, there are at least high-flow 
fistulae, aneurysm dilatation of nutrient arteries 
and location of fistulae.2,24,25 TCCE tools such 
as amplatzer duct occluder, microcoil and 
hydrocoil. Tool such as the double-umbrella 
device amplatzer duct occluder is used on a 
larger CAF with branches close to the location of 
coronary occlusion and more accurate placement. 
Orifice occlusion in a heart chamber with the 
surrounding location, then elected a specific coil 
or double-umbrella-sized two times the diameter 
of orifice.6,24,25
Issenberg microcoil first introduced in 
1990, initially used on a smaller CAF. Those 
advantages and the catheter sheath size smaller 
and cheaper prices.24,25 Selected microcoil 
diameter 20-50% larger than the largest diameter 
of the fistulae to prevent coil repositioning or 
migration. Gianturco coil, independent silicon, 
latex balloon or a combination of coils and 
balloons used as embolization material. TCCE 
tool most frequently used is the coil and is the 
largest type of platinum coil.7 Coil delivered 2.5 
Fr micro-catheter and the coil is released near 
the meandering arteries. One or more straight 
0.018-inch coil is used until there is complete 
obstruction and after micro-coil fixed to prevent 
distal migration. The advantage is to reduce 
the amount of coil needed to close the CAF, 
reduce costs and time.17 Microplex coil that can 
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be controlled from larger and has a stronger 
shape memory than conventional coil can be 
like an anchor, with an additional coil to close 
the shunt. During the procedure, the absolute 
placement of the micro-catheter is as deep as 
possible into the fistulae and the meticulous 
care during coil placement.7,9 Hydrocoil is a 
kind of hybrid-endovascular the coil material, 
used in large fistulae due to high-volume, low 
pressure due to expansion of the outer layer of a 
hydrophilic acrylic polymer gel which widened 
slowly and deployment capacity of up to nine 
times the volume since the first initial contact 
with the blood thus reducing the number of coils 
which needed to close fistulae or aneurysms 
of the aorta. For example using expandable 
hydrogel-coated platinum coils.17 Indication of 
therapy in these patients because of symptomatic 
fistulae and VES on ECG. Consideration of 
selection of TCCE treatment modality is the age 
and morphology fistulae. Fistulae of the LAD 
into the right atrium with a single drainage and 
there is no involvement of major blood vessels. 
Moreover, the patient is a geriatric patient with 
a complication of hypertension and DM2NO. 
TCCE procedure was performed on February 
17, 2010. Time required in this patient TCCE 73 
minutes. Time required similar reports Kabbani 
(2008) average 35±15 minutes.17 Evaluation post 
coil installation, chest pain disappeared even 
though remains VES on ECG. Complications 
in the post-TCCE include transient ischemia on 
ECG, whereas atrial arrhythmia, embolization 
coils outside and pulmonary artery dissection 
post fistulae.6 Re-occlusion angiography is 
required to view the nutrient arteries that should 
be closed during TCCE.24 Complications of CAF 
include congestive heart failure, pulmonary 
hypertension, ischemia, myocardial infarction. 
A rare complication of ruptured aneurysms and 
infective endocarditis.5,7
CONCLUSION
TCCE technique is the treatment choice in 
selected symptomatic CAF patients with a high 
success rate, saving cost and time compared 
to surgery. The goal of therapy is to prevent 
symptoms and complications especially in 
elderly. Clinical signs and increasing age are 
related to increased morbidity and mortality.
REFERENCES
1. Cason BA, Gordon HJ. Coronary steal caused by a 
coronary artery fistulae. J Cardiothoracic & Vascular 
Aenesthesia. 1992;6:65-7.
2. Qureshi SA. Coronary arterial fistulaes. Orphanet J 
Rare Dis. 2006;51:1750-2.
3. Renard C, Chivot C, Jarry G, Houpe D, Remond A, 
Leborge L. Communicating bilateral coronary artery 
to pulmonary fistulae with aneurysm in asymtomativ 
patient: Succesful conservative management with 
selective coil embolization of the aneurysm. Int J 
Cardiol. 2010.
4. Osawa H, Sakurada T, Sasaki J, Araki E. Successful 
surgical repair of a bilateral coronary-to-pulmonary 
artery fistulae. Ann Thoracic Cardiovasc Surg. 
2009;15:1.
5. Gowda RM, Vasavada BC, Khan IA. Coronary artery 
fistulaes: clinical and theurapetic considerations. Int’l 
J Cardiol. 2005;107:7-10.
6. Hoffer E, Materne P, Henroteaux D, Markov M, Boland 
J. Succesful percutaneus closure of multiple coronary 
artery fistulaes with coil embolization in two adults. 
Int’l J Cardiol. 2007;(122):e25-8.
7. Niizeki T, Daidouji H, Ootaki Y, Kaneko K, Ito M, 
Ogume M, Kubota I. Trancatheter coil embolization of 
coronary artery fistulaes: case report. J Cardiol Cases. 
2010;61:e1-e4.
8. Ata Y, Turk T, Bicer M, Yalcin M, Ata F, Yavuz S. 
Coronary arteriovenosus fistulaes in the adults: natural 
history and management strategies. J Cardiothoracic 
Surg. 2009;4:1-5.
9. Yu-Min S, Jun W, Gang Y, Yun Z, Yan Z, Zhi-qiang X. 
Coronary arteriovenosus fistulae with giant aneurysm 
formation treated with percutaneus intervention. 
Chinese Medical J. 2010;123:1.
10. Onorati F, Mastroroberto P, Bilotta M, Cristodoro L, 
Esposito A, Pezzo F, Renzulli A. Surgical treatment of 
coronary-to-pulmonary fistulae: how and when? Heart 
Vessels. 2006;21:321-4.
11.  Steinberg I, Baldwin JS, Dotter CT. Coronary 
arteriovenous fistulae. J Circulation. 1998;17:372-90.
12. Schechter DC. The classification of coronary artery 
fistulaes. Am Heart J. 1998:281-2.
13. Khan MG. Heart trouble encylopedia. Toronto: Toddart; 
1996.
14. Olgunturk R, Kula S, Tunaoglu FS. Transcatheter 
closure of a rare form of coronary arteriovenous 
fistulae. Int’l J Cardiol. 2006;113:261-3.
15. Mehta D, Redwood D, Ward DE. Multiple bilateral 
coronary arterial to pulmonary artery fistulae in 
asymptomatic patient. Int’l J Cardiology. 1997;16: 
96-8.
16. Braden DS, O’Neal KR, McMullan MR, Ebeid MR. 
Congenital coronary arteriovenosus fistulae presenting 
with syncope. Pediatric Cardiol. 2002;23:218-20.
17. Kabbani Z, Garcia-Nielsen L, Lozano ML, Febles T, 
Febles-Bethencourt L, Castro A. Coil embolization of 
coronary artery fistulaes. A single-centre experience. 
Cardiovascular revascularization Medicine. 2007;9: 
14-7.
60
Budi Y. Setianto                                                                                                                Acta Med Indones-Indones J Intern Med
18. Angelini P. Coronary artery anomalies-current clinical 
issues: definition, incidence, clinical relevance and 
treatment guidelines. Texas Heart J. 2002;29:271-8.
19. Koenig PR, Hijazi ZM. Congenital coronary 
abnormalities. UpToDate 2007. Version 15.1 diunduh 
16 Agustus 2010.
20 Bjork G, Crafoord C. Arteriovenosus aneurysma on the 
pulmonary artery simulating persistent ductusarteriosus 
botalli. Thorax. 1997;2:65.
21. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer 
GJ, Eagle KA, et al. ACC/AHA guidelines for coronary 
angiography. JACC. 1999;33(6):1-9.
22. DeMarla AN, Blanchard DG. The echocardiogram, 
Hurst’s the heart. 9th edition. In: Schlant RC, Alexander 
RW, Fuster V, eds. New York: McGraw-Hill; 1998. p. 
415-7.
23. Konno S, Endo M. Congenital coronary artery diseases. 
Kokyu To Junkan. 1993;21:378-409.
24. Armsby LR, Keane JF, Sherwood MC, Forbess JM, 
Perry SB, Lock JE. Management of coronary artery 
fistulaee: Patient selection and results of transcatheter 
closure. J Am Coll Cardiol. 2002;39:6.
25. Sreedharan M, Prasad G, Barooah B, Dash PK. Vortex 
coil embolisation of coronary artery fistulae. Intl J 
Cardiol. 2004;94:323-4.
